ATA91797A - Eine das vwf-propeptid enthaltende pharmazeutische präparation - Google Patents
Eine das vwf-propeptid enthaltende pharmazeutische präparationInfo
- Publication number
- ATA91797A ATA91797A AT0091797A AT91797A ATA91797A AT A91797 A ATA91797 A AT A91797A AT 0091797 A AT0091797 A AT 0091797A AT 91797 A AT91797 A AT 91797A AT A91797 A ATA91797 A AT A91797A
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical preparation
- preparation containing
- vwf propeptide
- vwf
- propeptide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0091797A AT405485B (de) | 1997-05-28 | 1997-05-28 | Eine das vwf-propeptid enthaltende pharmazeutische präparation |
DE69802918T DE69802918T2 (de) | 1997-05-28 | 1998-05-26 | Vwf propeptide enthaltendes pharmazeutisches präparat |
US09/424,498 US7005502B1 (en) | 1997-05-28 | 1998-05-26 | Pharmaceutical preparation comprising vWF propeptide |
AT98929378T ATE210455T1 (de) | 1997-05-28 | 1998-05-26 | Vwf propeptide enthaltendes pharmazeutisches präparat |
ES98929378T ES2168766T3 (es) | 1997-05-28 | 1998-05-26 | Preparacion farmaceutica que incluye el propeptido vwf. |
CA002288737A CA2288737A1 (en) | 1997-05-28 | 1998-05-26 | Pharmaceutical preparation comprising vwf propeptide |
AU79156/98A AU744643B2 (en) | 1997-05-28 | 1998-05-26 | Pharmaceutical preparation comprising vWF propeptide |
EP98929378A EP0977584B1 (de) | 1997-05-28 | 1998-05-26 | Vwf propeptide enthaltendes pharmazeutisches präparat |
JP50022099A JP4335978B2 (ja) | 1997-05-28 | 1998-05-26 | vWFプロペプチドを含む医薬調製物 |
PCT/EP1998/003090 WO1998053848A1 (en) | 1997-05-28 | 1998-05-26 | PHARMACEUTICAL PREPARATION COMPRISING vWF PROPEPTIDE |
NO19995843A NO324064B1 (no) | 1997-05-28 | 1999-11-29 | Farmasoytisk preparat omfattende vWF-propeptid samt fremgangsmate for fremstilling og anvendelse derav |
US11/218,406 US7557188B2 (en) | 1997-05-28 | 2005-09-01 | Methods of treating blood coagulation disorders using a pharmaceutical preparation comprising vWF propeptide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0091797A AT405485B (de) | 1997-05-28 | 1997-05-28 | Eine das vwf-propeptid enthaltende pharmazeutische präparation |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA91797A true ATA91797A (de) | 1999-01-15 |
AT405485B AT405485B (de) | 1999-08-25 |
Family
ID=3502803
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT0091797A AT405485B (de) | 1997-05-28 | 1997-05-28 | Eine das vwf-propeptid enthaltende pharmazeutische präparation |
AT98929378T ATE210455T1 (de) | 1997-05-28 | 1998-05-26 | Vwf propeptide enthaltendes pharmazeutisches präparat |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98929378T ATE210455T1 (de) | 1997-05-28 | 1998-05-26 | Vwf propeptide enthaltendes pharmazeutisches präparat |
Country Status (10)
Country | Link |
---|---|
US (2) | US7005502B1 (de) |
EP (1) | EP0977584B1 (de) |
JP (1) | JP4335978B2 (de) |
AT (2) | AT405485B (de) |
AU (1) | AU744643B2 (de) |
CA (1) | CA2288737A1 (de) |
DE (1) | DE69802918T2 (de) |
ES (1) | ES2168766T3 (de) |
NO (1) | NO324064B1 (de) |
WO (1) | WO1998053848A1 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1240900B1 (de) | 1999-12-24 | 2009-05-06 | Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute | Faktor viii oder von willebrand faktor zur behandlung von thrombopathie assoziierenden hämorrhagischen erkrankungen |
JP4663837B2 (ja) * | 1999-12-24 | 2011-04-06 | 一般財団法人化学及血清療法研究所 | 第▲viii▼因子を主成分とする血小板減少に伴う出血疾患の予防・治療用医薬組成物 |
PT1835938E (pt) | 2004-12-27 | 2013-11-06 | Baxter Int | Conjugados de polímero-factor de von willebrand |
KR20080108147A (ko) | 2006-03-31 | 2008-12-11 | 백스터 인터내셔널 인코포레이티드 | 페질화된 인자 viii |
US7645860B2 (en) | 2006-03-31 | 2010-01-12 | Baxter Healthcare S.A. | Factor VIII polymer conjugates |
US11197916B2 (en) | 2007-12-28 | 2021-12-14 | Takeda Pharmaceutical Company Limited | Lyophilized recombinant VWF formulations |
AR069989A1 (es) | 2007-12-28 | 2010-03-03 | Baxter Int | Formulaciones de vwf recombinantes |
ES2298096B1 (es) * | 2008-01-08 | 2009-01-01 | Grifols, S.A. | Procedimiento para la obtencion de un concentrado de factor von willebrand o del complejo de factor viii/factor von willebrand y utilizacionde los mismos. |
SI2349314T1 (sl) | 2008-10-21 | 2013-05-31 | Baxter International Inc. | Liofilizirane rekombinantne VWF formulacije |
NZ609908A (en) * | 2008-10-27 | 2014-07-25 | Baxter Int | Models of thrombotic thrombocytopenic purpura and methods of use thereof |
BR112012003802B1 (pt) | 2009-08-20 | 2022-10-25 | Takeda Pharmaceutical Company Limited | Método para remover um vírus sem envelope lipídico de uma solução |
US20110150843A1 (en) * | 2009-10-30 | 2011-06-23 | National Institute Of Immunology | Method for the therapeutic correction of hemophilia a by transplanting bone marrow cells |
US9700486B2 (en) | 2013-04-24 | 2017-07-11 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
KR102104843B1 (ko) | 2015-10-02 | 2020-04-28 | 에이에스엠엘 네델란즈 비.브이. | 계측 방법 및 장치, 컴퓨터 프로그램 및 리소그래피 시스템 |
CA3069295A1 (en) | 2017-07-07 | 2019-01-10 | Baxalta Incorporated | Treatment of gastrointestinal bleeding in patients with severe von willebrand disease by administration of recombinant vwf |
WO2019010496A1 (en) | 2017-07-07 | 2019-01-10 | Baxalta Incorporated | TREATMENT OF PATIENTS WITH A SERIOUS FORM OF VON WILLEBRAND'S DISEASE UNRESENGING SURGICAL INTERVENTION BY RECOMBINANT VWF ADMINISTRATION |
EA202092223A1 (ru) | 2018-03-21 | 2021-02-10 | Баксалта Инкорпорейтед | Разделение vwf и пропептида vwf хроматографическими методами |
EA202192140A1 (ru) | 2019-02-01 | 2021-12-15 | Такеда Фармасьютикал Компани Лимитед | СПОСОБЫ ПРОФИЛАКТИЧЕСКОГО ЛЕЧЕНИЯ РЕКОМБИНАНТНЫМ ФВ (рФВ) |
EP4028046B1 (de) | 2019-09-11 | 2024-02-14 | Takeda Pharmaceutical Company Limited | Verfahren zur behandlung im zusammenhang mit komplexen des von-willebrand-faktors und komplement c1q |
CA3169996A1 (en) | 2020-02-04 | 2021-08-12 | Takeda Pharmaceutical Company Limited | Treatment of menorrhagia in patients with severe von willebrand disease by administration of recombinant vwf |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT350726B (de) | 1976-08-30 | 1979-06-11 | Immuno Ag | Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma |
AT368883B (de) | 1980-07-22 | 1982-11-25 | Immuno Ag | Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen |
US4540573A (en) | 1983-07-14 | 1985-09-10 | New York Blood Center, Inc. | Undenatured virus-free biologically active protein derivatives |
AT378005B (de) | 1983-08-20 | 1985-06-10 | Linde Ag | Verfahren zum desoxidieren von metallschmelzen |
AT389815B (de) | 1984-03-09 | 1990-02-12 | Immuno Ag | Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten |
US5198349A (en) * | 1986-01-03 | 1993-03-30 | Genetics Institute, Inc. | Method for producing factor VIII:C and analogs |
AT390560B (de) | 1986-05-30 | 1990-05-25 | Immuno Ag | Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern |
US5849536A (en) * | 1990-03-02 | 1998-12-15 | Bio-Technology General Corp. | Cloning and production of human von willebrand factor GPIb binding domain polypeptides and methods of using same |
FR2673632A1 (fr) * | 1991-03-08 | 1992-09-11 | Lille Transfusion Sanguine | Procede de preparation de concentre de facteur von willebrand humain de tres haute purete, approprie a un usage therapeutique. |
AT402891B (de) | 1991-06-20 | 1997-09-25 | Immuno Ag | Verfahren zur herstellung eines inaktivierten blutproduktes |
AT398079B (de) | 1991-11-04 | 1994-09-26 | Immuno Ag | Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung |
WO1994013329A1 (de) | 1992-12-16 | 1994-06-23 | Immuno Aktiengesellschaft | Verfahren zur herstellung eines virussicheren biologischen präparates |
AT402788B (de) | 1993-08-03 | 1997-08-25 | Immuno Ag | Virussichere blutgerinnungsfaktor xiii-präparation |
JPH07330797A (ja) * | 1994-05-31 | 1995-12-19 | Sumitomo Metal Ind Ltd | 新規細胞接着活性ペプチド |
DE4437544A1 (de) * | 1994-10-20 | 1996-04-25 | Behringwerke Ag | Einsatz von vWF-enthaltenden Konzentraten als Kombinationstherapie bei Therapie mit Antithrombotika und Fibrinolytika |
AT404554B (de) | 1996-04-29 | 1998-12-28 | Immuno Ag | Pharmazeutische präparation |
US6068838A (en) | 1996-04-29 | 2000-05-30 | Baxter Aktiengesellschaft | Purified multimerase |
AT404359B (de) | 1996-04-29 | 1998-11-25 | Immuno Ag | Gereinigte multimerase |
-
1997
- 1997-05-28 AT AT0091797A patent/AT405485B/de not_active IP Right Cessation
-
1998
- 1998-05-26 WO PCT/EP1998/003090 patent/WO1998053848A1/en active IP Right Grant
- 1998-05-26 AU AU79156/98A patent/AU744643B2/en not_active Expired
- 1998-05-26 EP EP98929378A patent/EP0977584B1/de not_active Expired - Lifetime
- 1998-05-26 JP JP50022099A patent/JP4335978B2/ja not_active Expired - Lifetime
- 1998-05-26 AT AT98929378T patent/ATE210455T1/de active
- 1998-05-26 US US09/424,498 patent/US7005502B1/en not_active Expired - Lifetime
- 1998-05-26 DE DE69802918T patent/DE69802918T2/de not_active Expired - Lifetime
- 1998-05-26 ES ES98929378T patent/ES2168766T3/es not_active Expired - Lifetime
- 1998-05-26 CA CA002288737A patent/CA2288737A1/en not_active Abandoned
-
1999
- 1999-11-29 NO NO19995843A patent/NO324064B1/no not_active IP Right Cessation
-
2005
- 2005-09-01 US US11/218,406 patent/US7557188B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU744643B2 (en) | 2002-02-28 |
NO995843L (no) | 2000-01-27 |
EP0977584A1 (de) | 2000-02-09 |
DE69802918T2 (de) | 2003-04-10 |
AT405485B (de) | 1999-08-25 |
DE69802918D1 (de) | 2002-01-24 |
CA2288737A1 (en) | 1998-12-03 |
JP4335978B2 (ja) | 2009-09-30 |
NO995843D0 (no) | 1999-11-29 |
US7005502B1 (en) | 2006-02-28 |
US20060003921A1 (en) | 2006-01-05 |
WO1998053848A1 (en) | 1998-12-03 |
EP0977584B1 (de) | 2001-12-12 |
JP2001527579A (ja) | 2001-12-25 |
AU7915698A (en) | 1998-12-30 |
ATE210455T1 (de) | 2001-12-15 |
NO324064B1 (no) | 2007-08-06 |
ES2168766T3 (es) | 2002-06-16 |
US7557188B2 (en) | 2009-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATA91797A (de) | Eine das vwf-propeptid enthaltende pharmazeutische präparation | |
FI872756A0 (fi) | Med laserstraolning fungerande terapeutisk anordning. | |
ES2000428T3 (es) | Procedimiento para producir un medicamento para el tratamiento de la enfermedad de alzheimer, que contiene galantamina, y dispositivo medico correspondiente. | |
DE69008664D1 (de) | Bestrahlung von bluterzeugnissen. | |
DE3772429D1 (de) | Pharmazeutisches praeparat zur behandlung von peridontalkrankheiten. | |
IT8123070A0 (it) | Preparato che favorisce la coagulazione del sangue a base di proteine umani, nonche'procedimento per la preparazione | |
FI952169A0 (fi) | Stabiili valmiste veren koagulaatiohäiriöiden hoitamiseksi | |
NO902411D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer. | |
ATE132757T1 (de) | Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit | |
DE69814394D1 (de) | Verwendung von levobupivacain | |
IT1238825B (it) | Dispositivo per la correzione chirurgica dell'ametropia. | |
BG94738A (bg) | Използване на разтвор на йод за лечение на заболявания, свързани с йодна недостатъчност | |
IT9041503A0 (it) | Dispositivo per la cura chirurgica dell'ametropia | |
ES2059588T3 (es) | Factor xiii para la prevencion de una hemorragia intraventricular. | |
IT8721115A0 (it) | Fitopreparato per la cura di affezioni cutanee. | |
IT1198233B (it) | Metodo per la determinazione di anticorpi antisporozoita di p. falciparum nel sangue umano | |
NO881768D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner. | |
FI844645A0 (fi) | 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar. | |
ATA77095A (de) | Stabiles präparat zur behandlung von blutgerinnungsstörungen, enthaltend eine aktive gerinnungsfördernde stubstanz | |
ES2081279T3 (es) | Utilizacion de 15-desoxiespergualina como medicamento. | |
NO871477L (no) | Fremgangsmaate for fremstilling av human plasminogenaktivator. | |
DK301190A (da) | Bioforenelige, stof-specifikke reagenser til behandling af fysiologiske vaesker | |
ATE126437T1 (de) | Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf. | |
DE69734349D1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
DE69000791D1 (de) | Therapeutische mittel fuer metabolische knochenkrankheiten. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REN | Ceased due to non-payment of the annual fee | ||
EIH | Change in the person of patent owner | ||
PC | Change of the owner |
Owner name: BAXALTA INCORPORATED, US Effective date: 20160623 Owner name: BAXALTA GMBH, CH Effective date: 20160623 |
|
MK07 | Expiry |
Effective date: 20170528 |